Sitagliptin vs Avanafil: side-by-side comparison
Sitagliptin (DPP-4 inhibitor) and Avanafil (Phosphodiesterase type 5 (PDE5) inhibitor) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Sitagliptin | Avanafil |
|---|---|---|
| Therapeutic class | DPP-4 inhibitor | Phosphodiesterase type 5 (PDE5) inhibitor |
| CAS | 486460-32-6 | 330784-47-9 |
| ATC | A10BH01 | G04BE10 |
| Molecular weight | 407.31 g/mol | 483.95 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Sitagliptin and Avanafil share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Sitagliptin acts by a different mechanism than Avanafil, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Sitagliptin: Sitagliptin reversibly inhibits DPP-4, the serine protease responsible for rapid degradation of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Avanafil: Avanafil selectively inhibits phosphodiesterase type 5 (PDE5) in the corpus cavernosum, increasing cGMP and enhancing nitric-oxide-mediated vasodilation in response to sexual stimulation.
Indications compared
Sitagliptin: Sitagliptin is approved in adults with type 2 diabetes mellitus, alone or in combination with other antidiabetic agents, to improve glycaemic control. Avanafil: Avanafil is approved for erectile dysfunction in adult men.
Safety profile
Sitagliptin: Sitagliptin is generally well tolerated. Avanafil: The most common adverse effects are headache, flushing, nasal congestion and back pain — typical of the PDE5 class but generally less frequent than with older agents.
Frequently asked questions
Is Sitagliptin better than Avanafil? ▾
Sitagliptin and Avanafil are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Sitagliptin and Avanafil be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Sitagliptin
Products with Avanafil
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.